2nd Circ. Affirms Dismissal Of Adderall Pay-For-Delay Suit
The Second Circuit on Monday found that Shire LLC didn't block generic competition for its attention-deficit-hyperactivity drug Adderall XR, saying a lower court was correct to dismiss a consolidated class action...To view the full article, register now.
Already a subscriber? Click here to view full article